12:00 AM
 | 
Sep 07, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

EXO-226 inhibitor of glycated albumin regulatory update

Exocell received a notice of allowance for two U.S. patents covering its EXO-226 to...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >